Re: One Cancer Voice charities call for clarity on workforce funding announced in the Spending Review
We are following up our letter of 8th October to seek clarity and assurance that the announcement in the Spending Review: “The government will provide hundreds of millions of pounds in additional funding over the SR21 period to ensure a bigger and better trained NHS workforce” will meet the needs of people affected by cancer enabling the Government to deliver on its commitments on cancer diagnosis, survival and care.
We recognise and welcome commitments in the Spending Review, notably the additional investment to tackle the backlog and the capital investment for Community Diagnostic Centres which will play a critical role in improving diagnosis of cancer. However, we fear this investment will not deliver the desired outcome if it is not mirrored by an accompanying increase in staffing levels to deliver these services. We therefore seek urgent clarity on the level of funding that Health Education England will receive and how additional investment will be targeted.
In our previous correspondence we asked that you:
• Deliver on the Government’s manifesto pledge to plan for the cancer workforce by providing a multi-year settlement to train and employ more cancer staff to fill current vacancies and ensure that the workforce has the capacity to meet increasing demand, innovate and drive lifesaving research. Around £200m additional investment in Health Education England is needed over the 3 years to grow the key cancer professions by 45% by 2029.
• Create a Cancer Nurse Fund of £124 million to train the next generation of Cancer Nurse Specialists, helping to deliver on the NHS Long-Term Plan promise for every patient to get a named cancer nurse.
In response to the Parliamentary Petition to ‘Invest urgently in the NHS cancer workforce in the autumn Spending Review,’ the Government said: “Allocations and profiles will be confirmed as part of the Spending Review, which will set out the Government’s spending plans for health and social care for future years, including the NHS Workforce.”
We were therefore concerned that this detail was absent in the Spending Review announcement and associated documents.
Much depends on this funding.
You will be aware that our ask for investment in the cancer workforce reflects commitments in the NHS People Plan which states: “when the government further clarifies the available budget to expand the workforce and make sure that education and training is fit for the future – as expected to be set out in the forthcoming spending review – more details will follow.” We are keen to understand when more information will be made available and how we can support and inform that process.
You will be aware that there is widespread support for this investment in the NHS and cancer workforce. It is recognised by the Health and Social Care Select Committee through its cancer services inquiry, that a number of All Party Parliamentary Groups have jointly petitioned Government on this issue, and it is also backed by the public polling from Ipsos MORI which recently revealed the ‘biggest problems facing Britain’s healthcare system’ was not enough staff.
We want to support the Department and Health Education England in addressing this challenge. Long term investment in the cancer workforce is critical to clearing the cancer backlog in time, meeting early diagnosis targets and improving how we provide care. Without this action, to meet demand for diagnosis and care, patients will suffer and good investments announced last week will fail to deliver.
We look forward to your reply.
Yours Sincerely
Tina Seymour
CEO
Hope For Tomorrow
Jeannie Rigby
Chief Executive
Action Bladder Cancer UK
Will Jones
Chief Executive
Brains Trust
Jane Lyons
Chief Executive
Cancer 52
Michelle Mitchell OBE
Chief Executive
Cancer Research UK
Natalie Haskell
CEO
CoppaFeel!
Samantha Dixon
Chief Executive
Jo’s Cervical Cancer Trust
Zack Pemberton-Whiteley
Chief Executive
Leukaemia Care
Lynda Thomas
Chief Executive
Macmillan Cancer Support
Gillian Nuttall
Chief Executive
Melanoma UK
Tony Heddon
Chair
Neuroblastoma UK
Diana Jupp
Chief Executive
Pancreatic Cancer UK
Richard Davidson
Chief Executive
Sarcoma UK
Annwen Jones OBE
Chief Executive
Target Ovarian Cancer
Athena Lamnisos
Chief Executive
The Eve Appeal
Kathryn Scott
Chief Executive
Yorkshire Cancer Research
Rachel Kirby- Rider
CEO
Young Lives vs Cancer
Nick Turkentine
Chief Operating Officer
Kidney Cancer UK
Henny Braund
Chief Executive
Anthony Nolan
Baroness Delyth Morgan
Chief Executive
Breast Cancer Now
Genevieve Edwards
Chief Executive
Bowel Cancer UK
Robin Pritchard
Co-Director
Cancer Care Map
Ashley Gamble
Chief Executive
Children’s Cancer and Leukaemia Group
Colleen Shaw
Chief Executive
Friends of the Cancer Centre
Rose Woodward
Founder and Patient Advocate
Kidney Cancer Support Network
Fiona Hazel
Chief Executive
Leukaemia UK
Liz Darlison MBE
Chief Executive Officer
Mesothelioma UK
Victoria Clare
CEO
Ovacome
Angela Culhane
Chief Executive
Prostate Cancer UK
Gail Jackson
Chief Executive
Solving Children’s Cancer
Kate Collins
Chief Executive
Teenage Cancer Trust
Seren Hughes
Head of Engagement
CATTS
Professor Frank Chinegwundoh MBE
Chairperson
Cancer Black Care
Sarahjane Robertson
Chief Executive
Look Good Feel Better
Gemma Peters
Chief Executive
Blood Cancer UK
Pamela Healy OBE
Chief Executive
British Liver Trust
Sue Farrington Smith MBE
Chief Executive
Brain Tumour Research
John Symons
Director
Cancer of Unknown Primary Foundation – Jo’s friends
Marc Auckland
CLLSA Chair of Trustees
CLL Support Association
Dr Jen Kelly
Director
Grace Kelly Childhood Cancer Trust
Anna Jewell
Chair
Less Survivable Cancers Taskforce
Ropinder Gill
Chief Executive
Lymphoma Action
Sarah McDonald
Director of Research
Myeloma UK
Cary Wakefield
CEO
Ovarian Cancer Action
Mike Grundy
Deputy Chief Executive
Roy Castle Lung Cancer Foundation
Ken Mastris
Chairman
Tackle Prostate Cancer
Dr David Jenkinson
Chief Executive
The Brain Tumour Charity
Rachael Gormley
CEO
World Cancer Research Fund
Samantha Dixon
Chief Executive
Jo’s Cervical Cancer Trust
Nina Barough CBE
Chief Executive
Walk the Walk Worldwide